Form 13-F position report

IONIS PHARMACEUTICALS INC

Reported by Allworth Financial LP

IONS 0 04/01/26 CUSIP 462222AD2 Manager CIK 0001555170

Reported 0 shares, down 125,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2023
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 2 Through Q3 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-06-30 118556
2023-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

2 quarters
Quarterly reported position history for IONIS PHARMACEUTICALS INC held by Allworth Financial LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2023 Reduced 0 -125,000 (-100.0%) 0 $0 2023-10-31
Q2 2023 New 125,000 +125,000 (0.0%) < 0.01% $118,556 2023-07-18

Who else reported the position

64 managers reported IONIS PHARMACEUTICALS INC for Q3 2023.

Managers reporting IONIS PHARMACEUTICALS INC in Q3 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Nuveen Asset Management LLC New 15,500,000 +15,500,000 0.22% $633,330,000 1 qtr
STEELHEAD PARTNERS LLC Added 54,800,000 +50,800,000 3.15% $53,728,934 3 qtrs
BRAIDWELL LP Unchanged 52,740,000 0 1.64% $51,764,310 4 qtrs
LAZARD ASSET MANAGEMENT LLC New 45,733,000 +45,733,000 0.06% $44,886,000 6 qtrs
WOLVERINE ASSET MANAGEMENT LLC Unchanged 0 0 0.45% $40,173,472 6 qtrs
BlackRock Inc Reduced 32,392,000 -18,690,000 < 0.01% $31,630,788 6 qtrs
TENOR CAPITAL MANAGEMENT Co L P Added 32,000,000 +18,647,000 0.67% $31,366,123 6 qtrs
Magnetar Financial LLC Unchanged 0 0 0.71% $27,924,166 6 qtrs
CSS LLC IL Added 27,690,000 +3,224,000 1.78% $27,111,972 4 qtrs
CAMDEN ASSET MANAGEMENT L P CA Added 24,900,000 +20,250,000 0.9% $24,314,850 6 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2023
Filed
October 31, 2023
Filing type
13F-HR
Position type
NOTE 4/0

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.